BARDA awards contract to NewLink Genetics for Ebola vaccine development

The Biomedical Advanced Research and Development Authority (BARDA) of the US Department of Health and Human Services (HHS) has awarded a $24.8 million contract to a NewLink Genetics subsidiary to support the development of rVSV ∆G-ZEBOV GP (Ebola Zair…
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news